Drug ads can influence AI treatment recommendations, study finds
As people increasingly turn to artificial intelligence (AI) for health information, a new study by researchers at the Icahn School of Medicine at Mount Sinai raises questions about what happens when commercial advertising appears alongside a clinical question. The findings were reported in the Nov. 11 online issue of The Lancet Digital Health.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Thalamic responsive neurostimulation reduces seizures by over 80% in pediatric patients
United Kingdom
-
New 'FITdb' database reveals the genetic drivers of immune cell function
United Kingdom
-
New review of the first oral PCSK9 drug, a needle-free option for high cholesterol
United Kingdom
-
Long travel distances linked to higher pediatric surgery complication risks
United Kingdom
-
Prenatal cannabis use disorder linked to higher postpartum psychiatric emergency visits
United Kingdom
-
For your health—the large and growing benefits of being smoke-free
United Kingdom
-
Blocking serotonin receptors makes eye cancer cells sensitive to drugs
United Kingdom
-
Cataract surgery boosts work, income, and food security in Mozambique
United Kingdom